GlassScriptPhysician profile
Thomas J Price
NPI 1407342454
$6,209.74
in general payments reported to CMS, 2019-2025
13 companies · $1,028 in 2025
The $1,028 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.54 · 2020: $93.42 · 2021: $93.19 · 2022: $683 · 2023: $456 · 2024: $3,787 · 2025: $1,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,784 · Grant: $1,500 · Travel and Lodging: $629 · Education: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,784.06 |
| Grant | $1,500.00 |
| Travel and Lodging | $628.83 |
| Education | $358.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,934.07 | 2024 | Onyx Frontier, Corevalve Evolut R |
| Edwards Lifesciences Corporation | $1,247.54 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $620.96 | 2020-2024 | Lifevest |
| Biotronik INC. | $526.87 | 2022-2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Astrazeneca Pharmaceuticals LP | $402.34 | 2022-2023 | Farxiga, Brilinta |
| Abbott Laboratories | $307.21 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Navitor |
| Penumbra, INC. | $277.08 | 2025 | Indigo System |
| Boston Scientific Corporation | $212.67 | 2024-2025 | Avvigo Guidance System, Sq-Rx Pulse Generator |
| Shockwave Medical, INC | $204.52 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $187.78 | 2022-2025 | Igt Devices Undivided |
| Novo Nordisk INC | $177.17 | 2019-2025 | Ozempic |
| Abiomed | $86.29 | 2025 | |
| Atricure, INC. | $25.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.